TrialJournal of Korean medical science2021

Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial.

Ui Yoon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.